Overview

An Outpatient Study Investigating Non-prescription Treatments for COVID-19

Status:
Recruiting
Trial end date:
2021-03-31
Target enrollment:
Participant gender:
Summary
This is a platform study to investigate the effectiveness of a variety of non-prescription approaches for the treatment of non-hospitalized adults recently tested positive for COVID-19.
Phase:
Phase 2
Details
Lead Sponsor:
Profact, Inc.
Treatments:
Chlorine dioxide
Famotidine
Lactoferrin